2024-11-01 2025-10-31 2025-10-31 false 09281505 ZOZ Healthcare Limited 68100Buying and selling of own real estate iso4217:GBP xbrli:pure 092815052024-11-01 092815052025-10-31 092815052024-11-01 2025-10-31 09281505bus:SmallEntities2024-11-01 2025-10-31 09281505bus:AuditExempt-NoAccountantsReport2024-11-01 2025-10-31 09281505bus:FullAccounts2024-11-01 2025-10-31 09281505core:WithinOneYear2025-10-31 09281505core:AfterOneYear2025-10-31 09281505core:WithinOneYear2024-11-01 2025-10-31 09281505core:AfterOneYear2024-11-01 2025-10-31 09281505core:CurrentFinancialInstruments2025-10-31 09281505core:Non-currentFinancialInstruments2025-10-31 09281505core:CurrentFinancialInstruments2024-11-01 2025-10-31 09281505core:Non-currentFinancialInstruments2024-11-01 2025-10-31 09281505core:LandBuildings2024-11-01 2025-10-31 09281505core:FurnitureFittings2024-11-01 2025-10-31 09281505core:OfficeEquipment2024-11-01 2025-10-31 09281505core:Vehicles2024-11-01 2025-10-31 09281505core:PlantMachinery2024-11-01 2025-10-31 09281505core:OtherPropertyPlantEquipment2024-11-01 2025-10-31 09281505core:LandBuildings2025-10-31 09281505core:PlantMachinery2025-10-31 09281505core:Vehicles2025-10-31 09281505core:FurnitureFittings2025-10-31 09281505core:OfficeEquipment2025-10-31 09281505core:OtherPropertyPlantEquipment2025-10-31 09281505core:Right-of-useAssets2024-11-01 2025-10-31 09281505core:Right-of-useAssets2025-10-31 09281505core:Goodwill2024-11-01 2025-10-31 09281505core:PatentsTrademarksLicencesConcessionsSimilar2024-11-01 2025-10-31 09281505core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-11-01 2025-10-31 09281505core:OtherResidualIntangibleAssets2024-11-01 2025-10-31 09281505core:Goodwill2025-10-31 09281505core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-10-31 09281505core:PatentsTrademarksLicencesConcessionsSimilar2025-10-31 09281505core:OtherResidualIntangibleAssets2025-10-31 09281505dpl:CostSales2024-11-01 2025-10-31 09281505dpl:AdministrativeExpenses2024-11-01 2025-10-31 09281505dpl:DistributionCosts2024-11-01 2025-10-3109281505core:ShareCapital2025-10-31 09281505core:SharePremium2025-10-31 09281505core:RevaluationReserve2025-10-31 09281505core:OtherReservesSubtotal2025-10-31 09281505core:ShareCapitalPreferenceShares2025-10-31 09281505core:CapitalRedemptionReserve2025-10-31 09281505core:OtherCapitalReserve2025-10-31 09281505core:RetainedEarningsAccumulatedLosses2025-10-3109281505core:ShareCapital2024-11-01 2025-10-31 09281505core:SharePremium2024-11-01 2025-10-31 09281505core:RevaluationReserve2024-11-01 2025-10-31 09281505core:OtherReservesSubtotal2024-11-01 2025-10-31 09281505core:RetainedEarningsAccumulatedLosses2024-11-01 2025-10-310928150512024-11-01 2025-10-31 0928150522024-11-01 2025-10-3109281505core:ShareCapital12024-11-01 2025-10-31 09281505core:ShareCapital22024-11-01 2025-10-3109281505core:SharePremium12024-11-01 2025-10-31 09281505core:SharePremium22024-11-01 2025-10-3109281505core:RevaluationReserve12024-11-01 2025-10-31 09281505core:RevaluationReserve22024-11-01 2025-10-3109281505core:RetainedEarningsAccumulatedLosses12024-11-01 2025-10-31 09281505core:RetainedEarningsAccumulatedLosses22024-11-01 2025-10-310928150512024-11-01 2025-10-3109281505core:Non-currentFinancialInstrumentscore:CostValuation2024-11-01 09281505core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-10-31 09281505core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-10-31 09281505core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-10-31 09281505core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2025-10-31 09281505core:Non-currentFinancialInstrumentscore:CostValuation2025-10-3109281505core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2024-11-01 09281505core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-10-31 09281505core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-10-31 09281505core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-10-31 09281505core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2025-10-31 09281505core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-10-31 09281505core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-10-3109281505core:Non-currentFinancialInstruments2025-10-31 09281505core:Non-currentFinancialInstruments2024-10-31092815052023-11-01 092815052024-10-31 092815052023-11-01 2024-10-31 09281505core:WithinOneYear2024-10-31 09281505core:AfterOneYear2024-10-31 09281505core:CurrentFinancialInstruments2024-10-31 09281505core:Non-currentFinancialInstruments2024-10-31 09281505core:LandBuildings2024-10-31 09281505core:PlantMachinery2024-10-31 09281505core:Vehicles2024-10-31 09281505core:FurnitureFittings2024-10-31 09281505core:OfficeEquipment2024-10-31 09281505core:OtherPropertyPlantEquipment2024-10-31 09281505core:Right-of-useAssets2024-10-31 09281505core:Goodwill2024-10-31 09281505core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-10-31 09281505core:PatentsTrademarksLicencesConcessionsSimilar2024-10-31 09281505core:OtherResidualIntangibleAssets2024-10-31 09281505dpl:AdministrativeExpenses2023-11-01 2024-10-3109281505core:ShareCapital2024-10-31 09281505core:SharePremium2024-10-31 09281505core:RevaluationReserve2024-10-31 09281505core:OtherReservesSubtotal2024-10-31 09281505core:ShareCapitalPreferenceShares2024-10-31 09281505core:CapitalRedemptionReserve2024-10-31 09281505core:OtherCapitalReserve2024-10-31 09281505core:RetainedEarningsAccumulatedLosses2024-10-3109281505core:RetainedEarningsAccumulatedLosses2023-11-01 09281505core:ShareCapital2023-11-01 09281505core:SharePremium2023-11-01 09281505core:RevaluationReserve2023-11-01 09281505core:ShareCapital2023-11-01 2024-10-31 09281505core:SharePremium2023-11-01 2024-10-31 09281505core:RevaluationReserve2023-11-01 2024-10-31 09281505core:OtherReservesSubtotal2023-11-01 2024-10-31 09281505core:RetainedEarningsAccumulatedLosses2023-11-01 2024-10-310928150512023-11-01 2024-10-31 0928150522023-11-01 2024-10-3109281505core:ShareCapital12023-11-01 2024-10-31 09281505core:ShareCapital22023-11-01 2024-10-3109281505core:SharePremium12023-11-01 2024-10-31 09281505core:SharePremium22023-11-01 2024-10-3109281505core:RevaluationReserve12023-11-01 2024-10-31 09281505core:RevaluationReserve22023-11-01 2024-10-3109281505core:RetainedEarningsAccumulatedLosses12023-11-01 2024-10-31 09281505core:RetainedEarningsAccumulatedLosses22023-11-01 2024-10-3109281505bus:Director12024-11-01 2025-10-3109281505bus:Director22024-11-01 2025-10-3109281505bus:Director32024-11-01 2025-10-3109281505bus:PrivateLimitedCompanyLtd2024-11-01 2025-10-31
ZOZ Healthcare Limited
Unaudited Financial Statements
for the year ended 31 October 2025
Company registration number 09281505
(England and Wales)

Company Information

For the year ended 31 October 2025
Directors Arif, Seema Safia, Dr
Arif, Mohamed, Dr
Arif, Zoya Hafsa

Company secretary Arif, Seema Safia, Dr

Registered office White Gable 15 Millwood
Lisvane
Cardiff
CF14 0TL

Registered number 09281505

Accountant SAK2020 Limited T/A SNK Associates
Broadway House
9-10 Upper Clifton Street
Cardiff
Wales
CF24 1PU

Statement of Financial Position

As at 31 October 2025
2025
2024
£
£
£
£
Fixed assets
Tangible assets
250,109
235,135
250,109
235,135
Current assets
Cash at bank and in hand
8,339
41,467
8,339
41,467
Creditors
Amounts falling due within one year
(1,590)
(5,499)
(1,590)
(5,499)
Net current assets (liabilities)
6,749
35,968
Total assets less current liabilities
256,858
271,103
Creditors
Amounts falling due after one year
(157,639)
(157,639)
(157,639)
(157,639)
Net assets (liabilities)
99,219
113,464
Capital and reserves
Called up share capital
3
3
Profit and loss account
99,216
113,461
Total equity
99,219
113,464

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 31 July 2026 and are signed on its behalf by:

Arif, Seema Safia, Dr
Arif, Seema Safia, Dr
Director
Arif, Mohamed, Dr
Arif, Mohamed, Dr
Director
Arif, Zoya Hafsa
Arif, Zoya Hafsa
Director

Company registration number 09281505

Notes to the Financial Statements

For the year ended 31 October 2025

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

3. Employees

The average number of employees during the year was 3 (2024: 3).